N-Acetyl-l-cysteine (NAC) is an antioxidant and anti-inflammatory agent with significant
potential in clinical applications including stroke and neuroinflammation. The drug shows …

Understanding and improving drug release kinetics from dendrimer–drug conjugates are
key steps to improve their in vivo efficacy. N-Acetyl cysteine (NAC) is an anti-inflammatory …

Dendrimer‐N‐acetyl cysteine (D‐NAC) conjugate has shown significant promise in multiple
preclinical models of brain injury and is undergoing clinical translation. D‐NAC is a …

Dendrimers are emerging as potential intracellular drug delivery vehicles. Understanding
and improving the cellular efficacy of dendrimer–drug conjugates, can lead to significant in …

Dendrimers comprise a category of branched materials with diverse functions that can be
constructed with defined architectural and chemical structures. When decorated with …

Nanocarriers with low toxicity, high stability, long circulation in blood and triggered drug
release at target sites are extremely needed for cancer therapy. In this study, different molar …

We present here the development of multifunctional doxorubicin (DOX)-conjugated poly
(amidoamine)(PAMAM) dendrimers as a unique platform for pH-responsive drug release …

Abstract N-acetyl-d-glucosamine-labelled dendrimers (NAG-Dend) were synthesized for the
targeted delivery of camptothecin (CPT) to A549 human lung adenocarcinoma cells, which …

Dendrimers have emerged as promising multifunctional nanomaterials for drug delivery due
to their well-defined size and tailorability. We compare two schemes to obtain …

Dendritic nanostructures can play a key role in drug delivery, due to the high density and
variety of surface functional groups that can facilitate and modulate the delivery process. We …